Related Experiment Video

Updated: Mar 21, 2026

Author Spotlight: Uncovering the Role of Mitochondrial Calcium Phosphate in Heart Failure and Bioenergetics
07:03

Author Spotlight: Uncovering the Role of Mitochondrial Calcium Phosphate in Heart Failure and Bioenergetics

Published on: August 23, 2024

1.6K

Mitochondrial pathways to cardiac recovery: TFAM

George H Kunkel1, Pankaj Chaturvedi2, Suresh C Tyagi1

  • 1Department of Physiology and Biophysics, Health Sciences Centre, 1216, School of Medicine, University of Louisville, 500, South Preston Street, Louisville, KY, 40202, USA.

Heart Failure Reviews
|May 12, 2016
PubMed

Insights

Mitochondrial transcription factor A (TFAM) shows promise in rescuing mitochondria and preventing heart failure. TFAM-packed exosomes offer a novel therapeutic approach to mitigate mitochondrial dysfunction in cardiomyocytes.

Area of Science:

  • Cardiology
  • Mitochondrial Biology
  • Cellular Resuscitation

Background:

  • Mitochondrial dysfunction is implicated in numerous pathologies, yet effective rescue strategies are limited.
  • Mitochondrial transcription factor A (TFAM) regulates mitochondrial DNA and cellular respiration, crucial for cardiomyocyte health.
  • Cardiomyocyte death in heart failure is linked to calcium mishandling and reactive oxygen species (ROS) production.

Purpose of the Study:

  • To investigate the cardioprotective role of TFAM in mitigating mitochondrial dysfunction.
  • To explore the therapeutic potential of TFAM-packed exosomes (TFAM-PE) for cellular resuscitation in heart failure models.

Main Methods:

  • Investigated TFAM's regulatory functions over key proteins like serca2a, NFAT, and Lon protease.
  • Examined the role of TFAM in mitigating calcium mishandling and ROS production.
  • Proposed exosomal delivery of TFAM as a novel therapeutic strategy.

Main Results:

  • TFAM's regulatory functions contribute to cardiomyocyte stability by managing calcium and ROS levels.
  • Upregulation of proteases like calpains and MMPs is observed in failing hearts.
  • TFAM-PE is hypothesized to therapeutically mitigate mitochondrial dysfunction.

Conclusions:

  • TFAM plays a critical role in maintaining mitochondrial integrity and cardiomyocyte function.
  • Exosomal delivery of TFAM represents a novel therapeutic avenue for heart failure.
  • Further research is warranted to elucidate TFAM's full therapeutic potential in cardiac pathologies.
Keywords:
CalpainHsp60MMPsMitochondriaSerca2aTFAM

More Related Videos

A Flow Cytometry-based Assay for Measuring Mitochondrial Membrane Potential in Cardiac Myocytes After Hypoxia/Reoxygenation07:14

A Flow Cytometry-based Assay for Measuring Mitochondrial Membrane Potential in Cardiac Myocytes After Hypoxia/Reoxygenation

Published on: July 13, 2018

15.4K
Construction of Defined Human Engineered Cardiac Tissues to Study Mechanisms of Cardiac Cell Therapy11:51

Construction of Defined Human Engineered Cardiac Tissues to Study Mechanisms of Cardiac Cell Therapy

Published on: March 1, 2016

11.0K

Related Concept Videos

Muscle Recovery and Fatigue01:24

Muscle Recovery and Fatigue

Muscle fatigue refers to the decline in a muscle's ability to maintain the force of contraction after prolonged activity. It primarily stems from changes within muscle fibers. Even before experiencing muscle fatigue, one may feel tired and have the urge to stop the activity. This response, known as central fatigue, occurs due to changes in the central nervous system, namely the brain and spinal cord. While there is no single mechanism that induces fatigue, it may serve as a protective...
4.8K
Pathophysiology of Cardiac Performance01:29

Pathophysiology of Cardiac Performance

Typical heart performance is influenced by heart rate, rhythm, myocardial contraction, and metabolism or blood flow. The cardiac muscle exhibits distinct electrophysiological features, including pacemaker activity and calcium channel control, which play a vital role in the heart's response to various drugs. The autonomic nervous system, comprising the sympathetic and parasympathetic branches, regulates heart rate. Sympathetic activation increases heart rate, while parasympathetic activation...
1.9K
Electron Transport Chain: Complex I and II01:46

Electron Transport Chain: Complex I and II

The mitochondrial electron transport chain (ETC) is the main energy generation system in the eukaryotic cells. However, mitochondria also produce cytotoxic reactive oxygen species (ROS) due to the large electron flow during oxidative phosphorylation. While Complex I is one of the primary sources of superoxide radicals, ROS production by Complex II is uncommon and may only be observed in cancer cells with mutated complexes.
ROS generation is regulated and maintained at moderate levels necessary...
19.5K
Mitochondrial Precursor Proteins01:39

Mitochondrial Precursor Proteins

Mitochondrial precursors are partially unfolded or loosely folded polypeptide chains. Newly synthesized precursors are inhibited from spontaneously folding into their native conformation by the cytosolic chaperones, heat shock proteins 70 (Hsp70), and mitochondrial import stimulation factors (MSFs). Precursors bound to MSFs are guided to the TOM70-TOM37 receptors, while precursors bound to Hsp70  chaperones are targetted to TOM20-TOM22 receptor complexes.
Most of the mitochondrial...
3.9K
Other Glycolytic Pathways01:24

Other Glycolytic Pathways

The pentose phosphate pathway (PPP) operates in parallel with glycolysis, facilitating the metabolism of both pentoses and glucose. This pathway consists of two distinct phases: the oxidative and non-oxidative phases. While it does not directly generate ATP, the intermediates formed during the process can integrate into glycolysis, contributing to cellular energy metabolism when required.Oxidative Phase: NADPH ProductionThe oxidative phase of the pentose phosphate pathway is primarily...
1.1K